Regeneron Pharmaceuticals's CEO Salary
- Daniel P. Van Plew Executive Vice President and General Manager, Industrial Operations and Product Supply at Regeneron Pharmaceuticals, received a total compensation of $8.66 M in 2024.
- Andrew J. Murphy, Ph.D. Executive Vice President, Research at Regeneron Pharmaceuticals, received a total compensation of $8.36 M in 2024.
- Leonard S. Schleifer, M.D., Ph.D. Board co-Chair, President and Chief Executive Officer at Regeneron Pharmaceuticals, received a total compensation of $6.82 M in 2024.
- George D. Yancopoulos, M.D., Ph.D. Board co-Chair, President and Chief Scientific Officer at Regeneron Pharmaceuticals, received a total compensation of $6.80 M in 2024.
- Christopher Fenimore Executive Vice President, Finance and Chief Financial Officer 6 at Regeneron Pharmaceuticals, received a total compensation of $6.27 M in 2024.
- Robert E. Landry (retired) Former Executive Vice President, Finance and Chief Financial Officer at Regeneron Pharmaceuticals, received a total compensation of $281.98 K in 2024.
Regeneron Pharmaceuticals's CEO salary and other executives compensation in 2024 was as follows:
Executive Compensation Summary Table
| 2024 | 2023 | 2022 | |
|---|---|---|---|
| Daniel P. Van Plew Executive Vice President and General Manager, Industrial Operations and Product Supply | $8.66 M | $8.76 M | $8.85 M |
| Base Salary | $964.10 K | $931.50 K | $900.00 K |
| Incentive Plan Compensation | $914.93 K | $1.05 M | $1.02 M |
| All Other Compensation | $26.45 K | $26.20 K | $36.50 K |
| Stock Award | $2.70 M | $2.70 M | $2.76 M |
| Andrew J. Murphy, Ph.D. Executive Vice President, Research | $8.36 M | $8.43 M | $9.12 M |
| Base Salary | $803.60 K | $776.25 K | $750.00 K |
| Incentive Plan Compensation | $783.51 K | $877.94 K | $848.25 K |
| All Other Compensation | $26.45 K | $26.20 K | $24.70 K |
| Stock Award | $2.70 M | $2.70 M | $3.00 M |
| Leonard S. Schleifer, M.D., Ph.D. Board co-Chair, President and Chief Executive Officer | $6.82 M | $8.18 M | $7.00 M |
| Base Salary | $1.94 M | $1.88 M | $1.81 M |
| Incentive Plan Compensation | $3.49 M | $4.28 M | $4.13 M |
| All Other Compensation | $1.39 M | $2.03 M | $1.06 M |
| Stock Award | - | - | - |
| George D. Yancopoulos, M.D., Ph.D. Board co-Chair, President and Chief Scientific Officer | $6.80 M | $7.76 M | $6.59 M |
| Base Salary | $1.94 M | $1.88 M | $1.81 M |
| Incentive Plan Compensation | $3.49 M | $4.28 M | $4.13 M |
| All Other Compensation | $1.36 M | $1.61 M | $650.35 K |
| Stock Award | - | - | - |
| Christopher Fenimore Executive Vice President, Finance and Chief Financial Officer 6 | $6.27 M | - | - |
| Base Salary | $660.00 K | - | - |
| Incentive Plan Compensation | $594.00 K | - | - |
| All Other Compensation | $15.25 K | - | - |
| Stock Award | $2.00 M | - | - |
| Robert E. Landry (retired) Former Executive Vice President, Finance and Chief Financial Officer | $281.98 K | $1.90 M | $8.84 M |
| Base Salary | $255.53 K | $881.41 K | $851.60 K |
| Incentive Plan Compensation | - | $996.87 K | $963.16 K |
| All Other Compensation | $26.45 K | $26.20 K | $24.70 K |
| Stock Award | - | - | $2.80 M |
| Daniel P. Van Plew Executive Vice President and General Manager, Industrial Operations and Product Supply | - | $8.76 M | $8.85 M |
| Base Salary | - | $931.50 K | $900.00 K |
| Incentive Plan Compensation | - | $1.05 M | $1.02 M |
| All Other Compensation | - | $26.20 K | $36.50 K |
| Stock Award | - | $2.70 M | $2.76 M |
| Andrew J. Murphy, Ph.D. Executive Vice President, Research | - | $8.43 M | $9.12 M |
| Base Salary | - | $776.25 K | $750.00 K |
| Incentive Plan Compensation | - | $877.94 K | $848.25 K |
| All Other Compensation | - | $26.20 K | $24.70 K |
| Stock Award | - | $2.70 M | $3.00 M |
| Leonard S. Schleifer, M.D., Ph.D. Board co-Chair, President and Chief Executive Officer | - | $8.18 M | $7.00 M |
| Base Salary | - | $1.88 M | $1.81 M |
| Incentive Plan Compensation | - | $4.28 M | $4.13 M |
| All Other Compensation | - | $2.03 M | $1.06 M |
| Stock Award | - | - | - |
| George D. Yancopoulos, M.D., Ph.D. Board co-Chair, President and Chief Scientific Officer | - | $7.76 M | $6.59 M |
| Base Salary | - | $1.88 M | $1.81 M |
| Incentive Plan Compensation | - | $4.28 M | $4.13 M |
| All Other Compensation | - | $1.61 M | $650.35 K |
| Stock Award | - | - | - |
| Robert E. Landry (retired) Former Executive Vice President, Finance and Chief Financial Officer | - | $1.90 M | $8.84 M |
| Base Salary | - | $881.41 K | $851.60 K |
| Incentive Plan Compensation | - | $996.87 K | $963.16 K |
| All Other Compensation | - | $26.20 K | $24.70 K |
| Stock Award | - | - | $2.80 M |
| Robert E. Landry Executive Vice President, Finance and Chief Financial Officer | - | - | $8.84 M |
| Base Salary | - | - | $851.60 K |
| Incentive Plan Compensation | - | - | $963.16 K |
| All Other Compensation | - | - | $24.70 K |
| Stock Award | - | - | $2.80 M |
| Leonard S. Schleifer, M.D., Ph.D. President and Chief Executive Officer | - | - | $7.00 M |
| Base Salary | - | - | $1.81 M |
| Incentive Plan Compensation | - | - | $4.13 M |
| All Other Compensation | - | - | $1.06 M |
| Stock Award | - | - | - |
| Marion McCourt Executive Vice President, Commercial 10 | - | - | $6.90 M |
| Base Salary | - | - | $706.30 K |
| Incentive Plan Compensation | - | - | $780.46 K |
| All Other Compensation | - | - | $13.50 K |
| Stock Award | - | - | $2.16 M |
| George D. Yancopoulos, M.D., Ph.D. President and Chief Scientific Officer | - | - | $6.59 M |
| Base Salary | - | - | $1.81 M |
| Incentive Plan Compensation | - | - | $4.13 M |
| All Other Compensation | - | - | $650.35 K |
| Stock Award | - | - | - |
